EFFECTOR CELL BLOCKADE : A NEW MECHANISM OF IMMUNE HYPOREACTIVITY INDUCED BY MULTIVALENT ANTIGENS by Schrader, John W. & Nossal, G. J. V.
EFFECTOR  CELL  BLOCKADE 
A  NEW  MECHANISM OF  IMMUNE HYPOREACTIVITY INDUCED BY 
MULTIVALENT ANTIGENS* 
BY JOHN W.  SCHRADER~t AND G. J.  V.  NOSSAL 
(From The Walter and Eliza Hall Institute of Medical Research, Melbourne, 
Victoria 3050,  Australia) 
(Received for publication 27 December 1973) 
Of the  many model  antigens  that  have  been  used  to  elucidate  the  mechanisms 
of  immunological  nonresponsiveness,  two  groups  have  been  especially  popular. 
These are heterologous serum proteins (1) and highly multivalent,  polymeric antigens 
such  as  pneumococcal polysaccharides  (2)  or polymerized  flagellin  (POL)'  (3).  In 
recent years haptens  have been  conjugated  to such  tolerogens,  and  hapten-specific 
tolerance at the level of the B lymphocyte has been measured. Though antigens from 
each group can cause B-cell nonresponsiveness under appropriate circumstances, the 
latter group exhibits some features which differentiate it from the former. These in- 
clude  strong  immunogenicity in  low  (subtolerogenic)  dosage,  independence  of  help 
from T lymphocytes, a major IgM component to the primary response, and, in  some 
cases,  an adjuvantlike action. In fact, at least two antigens of this group which have 
been shown to be good in vitro B-cell tolerogens, namely bacterial lipopolysaccharide 
(4) and POL (3), actually possess the capacity to prevent the induction of B-cell toler- 
ance by high doses of soluble  serum proteins (5, 6). This suggests the possibility that 
the mulfivalent, T-cell independent antigens cause unresponsiveness through a differ- 
ent mechanism than that pertaining for soluble serum proteins. 
In this paper, evidence is presented to show that highly multivalent antigens 
can  specifically  suppress  immune  responses  at  the  level  of  the  effector cell, 
namely  the  actual  antibody-forming cell  (AFC),  by producing  a  substantial 
depression  of antibody secretion rates of individual  AFC. Thus in the case of 
thymus-independent antigens the possibility is raised that, under some experi- 
mental  situations  at  least,  the  phenomenon  previously believed  to  represent 
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tolerance, in the sense of a  failure of progenitors of AFC  to become activated, 
may actually be an effector cell blockade. 
Materials and Methods 
Antigens.--POL  was  prepared  from  flagella of  Salmonella  adelaide  (7).  Fowl  gamma 
globulin  (FGG),  prepared  from serum  by precipitation  with sodium sulphate  (8),  human 
gamma globulin (HGG)  (C.S.L., Parkville, Melbourne), and gelatine (Parke, Davis and Co., 
Sydney)  were  dinitrophenylated  (DNP-FGG,  DNP-HGG,  and  DNP-gel)  using  dinitro- 
benzene-sulphonie acid  (Eastman Kodak Co., Rochester, N.  Y.)  as detailed elsewhere  (9). 
The average conjugation ratios of the DNP-POL preparations  used ranged from 1.0 to 2.9 
tool of DNP per mole of monomeric flagellin (tool wt 40,000 daltons). The conjugation ratios 
of DNP-HGG preparations used were 4.5 and 20 tool of DNP per HGG. The DNP-gelatine 
had an average of 20 DNP groups per 100,000 dalton Unit of gelatine. DNP-lysine (B.D.H., 
Melbourne, Australia) was conjugated to lipopolysaecharide (LPS)  (Difco Laboratories, Inc., 
Detroit, Mich.) using a carbodiimide reagent, 1-cyclohexy-3-(2-morpholinoethyl)-carbodiimide 
metho-p-toluenesulphonate (Aldrich Chemical Co., Milwaukee, Wis.). Complexes of FGG and 
POL were prepared  by mixing POL with an antiserum  raised in the domestic fowl against 
POL and washing the precipitate with saline (Schrader and Feldmann, manuscript in prepara- 
tion).  DNP-~-amino-caproic  acid  (DNP-CAP)  was  obtained  from  B.D.H,  Melbourne, 
Australia. DNP-DGL was obtained from Dr. David Katz. 
Mice.--CBA/H/Wehi mice were used at 8-12 wk of age at first immunization. 
Immunization.--Mice  were immunized with DNP-POL 5 #g intraperitoneally  (i.p.)  and 
used from two to 7 days afterwards.  For studies  on the secondary response, mice were in- 
jected i.p. with alum-precipitated DNP-FGG, 500/~g, plus pertussis organisms (2 X  l0  T per 
mouse), and 1-3 mo later were boosted with an i.p. injection of 50 #g of soluble DNP-FGG. 
Plaque-Forming Cell (PFC) Assay.--The  hemolytic  plaque  technique  of  Cunningham 
and Szenberg (10) was used, suitably modified to detect  hapten-  (9) or protein-specific (I1, 
12) PFC. Unless otherwise stated, PFC assays were read after 60 min at 37°C,  this period in- 
cluding a temperature equilibration time, since the assay mixtures were initially at 0°C and 
the assay chambers at room temperature. Routine assays were scored at 25-fold magnification 
with a colony microscope. 
Preparation of Cell Suspensions.--Mice  were killed  by cervical dislocation,  the  spleens 
dissociated using tweezers, and the cell suspension washed once in cold Eisen's balanced salt 
solution  (EBSS). Cells were suspended  in Eagle's minimal essential medium  (Grand Island 
Biological Co.,  Grand  Island,  N.  Y.)  which was  supplemented  with  5%  fetal calf serum 
(FCS)  (C.S.L.,  Parkville,  Melbourne),  and  buffered with  Hepes  (Calbiochem,  San  Diego, 
Calif.) (HEM). 
Preincubation and Washing of Spleen CeUs.--A preliminary assay was performed on the 
spleen cell suspension and the concentration of,cells adjusted with HEM so that there were 
approximately  1,000 PFC/ml. Portions  (0.5 ml)  of the suspension  (generally one spleen in 
5-20 mls) were then incubated with varying amounts of the inhibiting antigen at 37°C or 0°C 
for varying periods. The cell suspensions were diluted with ice-cold HEM, washed twice by 
centrifugation through an FCS underlayer, resuspended, and assayed for PFC. 
Mioromanipulation Studies.--An  open modification of the hemolytic plaque technique was 
used,  in  conjunction  with  micromanipulation  techniques  as  described  elsewhere  (13, 14). 
Briefly, a starting population of PFC was generated by placing immunized spleen cells in a 
plaque-revealing mixture in a series of large microdroplets (approximately 1 121) on glass slides 
under paraffin oil. In some cases, the cell suspension had been preineubated for 30 rain at 37  ° 
with multivalent antigen, and washed twice, before generating plaques ("preinhibited PFC"). 
Microscope and micromanipulator were at 37°C in a plastic incubator for some experiments 
and  at  room  temperature  (approximately  20°C)  for  others.  In  experiments  where it  was 1584  EFFECTOR  CELL  BLOCKADE 
desired  to  place PFC  into 125I-labeled  antiglobulin at  0°C,  slides bearing the appropriate 
microdrops and all necessary media as well as the coveting paraffin, were held on packed ice, 
except for the actual few minutes taken for the micromanipulation step, which was performed 
with the microscope at room temperature. When a hemolytic plaque was identified with only 
a single, central PFC, this cell was removed by micromanipulation, washed twice in droplets 
of clean medium, and processed for further study. 
Delection of Cell Surface Ig on Single PFC by Quantitative Radioautograpky.--The  tech- 
nique was slightly modified from that described previously  (14).  Individual PFC that  had 
come from preinkibited or normal plaques were washed twice and held at 0 ° or 37°C, usually 
for 30 min. with an 125I-labeled antiglobulin. The reagent used was a strong, polyvalent rabbit 
antimouse Ig,immunoglobulin previously described in detail (R19NS),  (15).  It was used at a 
concentration of 0.1 #g/ml, with 0.5-0.6 [125I]atoms/mol of Ig. After two further washes by 
micromanipulation,  the  single  cells  were  manipulated  onto  premarked  spots  on  gelatin- 
coated slides, processed for radioautography with Kodak NTB2 emulsion, exposed for 3 days, 
developed, stained with Giemsa, and the resultant grains counted at X  1,250 magnification. 
RESULTS 
Inhibition  of  Plaque-Formation  by  Prior  Incubation  of  Spleen  Cells  with 
DNP-POL.--Most  experiments were  performed with  AFC  that  made  anti- 
DNP antibody of the IgM class and that were contained in spleen cell suspen- 
sions from mice injected 3-5  days previously with  DNP-POL  (5  #g i.p.).  If 
before assay, the spleen cells were incubated at 37°C with DNP-POL and then 
washed thoroughly, the number and quality of plaques were reduced in com- 
parison  with  the  results  of assays  of control  aliquots  incubated  in  medium 
alone and washed in parallel. The degree of inhibition varied with the concen- 
tration of DNP-POL, (Fig. 1) or incubation time (Table I). 1-h incubation in 
medium alone caused a slight but definite loss in PFC numbers as observed by 
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FIG. 1.  The effect of varying the dose of DNP-POL in the preincubation mixture. Portions 
of spleen cell suspensions containing anti-DNP-AFC were incubated at 37°C for 30 min with 
varying concentrations of DNP-POL. Mter washing twice, the cells were suspended in 1 ml 
HEM.  Assays were made in two cohorts, one being read after 60 rain incubation (O--e) 
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Hiramoto et al. (16), but 60 min in inhibitor caused an almost total elimination 
of PFC. With 30 rain of preincubation in medium alone at 37°C, the nonspecific 
loss of PFC was essentially eliminated, and the specific inhibition was somewhat 
less marked.  This shorter incubation time was used for most experiments. 
Another control, both for nonspecific deterioration of PFC and for nonspecific 
toxicity of multivalent conjugates, was to include in the cell suspension a second 
population  of PFC,  directed against  an irrelevant antigen.  Table II illustrates 
TABLE I 
The Effect of Variation  of the  Time of Preincubation with DNP-POL 
Pretreatment  Anti-DNP PFC/chamber 
100 ~g DNP-POL  Incubation  time  Numberst  % 
r~n 
+  60  4,  9  5 
--  60  99,  99  83 
+  30  26,  40  27 
--  30  129,  115  100 
--  --*  134,  121  104 
A spleen cell suspension prepared from two CBA mice injected 3 days before with DNP- 
POL, was diluted with HEM so as to contain approximately 2,500 AFC/ml. Portions of 0.3 
ml were incubated with or without DNP-POL at 37°C for either 60 min or 30 rain. All groups 
of cells were washed twice in 10 ml of cold EBSS and resuspended to 0.6 ml in HEM. Dupli- 
cate 0.1-ml portions were assayed for anti-DNP-AFC along with aliquots from the original 
suspension* which had not been incubated or washed. Results are shown as the actual PFC 
numbers per chamber,:~ or the mean PFC/chamber expressed as the percentage of the mean 
PFC in the assay of the control group incubated with medium alone for 30 min. 
TABLE II 
Specificity of the Effect of Preincubation with DNP-POL 
Concentration of DNP-POL* 
% PFC/chamber 
Anti-DNP  Anti-FGG 
ag/vd 
400  40-4-1  1044-2 
100  45  4-  9  99  -4-  4 
10  90  -4-  4  97  4-  2 
1  93  4-  1  101  -4-  2 
--  100  100 
Spleen cells from mice injected 4 days previously with DNP-POL, 5 #g and from other 
mice injected 4 days previously with FGG, 100 ~g, plus POL 10 #g, as an adjuvant  (manu- 
script in preparation), were assayed for anti-DNP and anti-FGG-AFC and then diluted and 
mixed so that 1 ml of the final suspension contained approximately 1,000 AFC of each speci- 
ficity. Duplicate portions ot 0.5 ml were incubated for 30 min at 37°C with varying concen- 
trations of DNP-POL*, and  washed twice before duplicate assays were set up for AFC of 
each specificity. Results are pooled from four experiments and are normalized, with the AFC 
counts in control portions being taken as 100%. 1586  EFFECTOR  CELL BLOCKADE 
the results of four typical experiments which showed that, while DNP-POL 
inhibited anti-DNP plaques, it had no effect on anti-FGG plaques. 
Tables I  and II present counts of all plaques detected, regardless of size or 
morphologic characteristics. However, simple observation showed that  those 
plaques  remaining in  DNP-SRC  monolayers after pretreatment  of  the  cell 
suspension with DNP-POL  were  consistently smaller and more  turbid  than 
control  plaques.  Thus,  the  inhibition phenomenon at  the  single  PFC  level 
appeared not to be an "all or none" effect. Rather, the changed appearance of 
residual plaques  suggested that all PFC  showed a  reduced rate of antibody 
secretion. The following experiments supported this suggestion. 
Time of Appearance of Normal and Preinhibited Plaques.--Fig. 2 shows the 
effect of varying the time of incubation of the assay chambers.  Clearly, pre- 
inhibited PFC showed a delayed time of plaque appearance. The lower curve 
in Fig. 1 represents the results of readings at 30 min of assays of aliquots pre- 
inhibited with varying doses of DNP-POL and demonstrates the same phe- 
nomenon. 
Effects of Suboptimal Plaque-Revealing Conditions.--The results displayed in 
Table III show that decreasing the efficiency of the plaque-revealing system by 
limiting the amount of complement or increasing the DNP-SRC concentration 
increased  the  difference between  PFC  numbers  in  aliquots  of  DNP-POL- 
treated and control suspensions. These results suggest that PFC are not being 
deleted, for example by complement-mediated lysis, but rather that their rate 
of effective antigen secretion is being diminished. Obviously, at cell secretion 
rates  below  a  threshold determined by the  sensitivity of the  plaque  assay, 
AFC will be no longer detectable at all as PFC. 
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FIG. 2.  Time of appearance of PFC in assays of DNP-POL treated anti-DNP AFC sus- 
pensions. Portions of a  spleen-cell suspension were incubated in the presence or absence  of 
DNP-POL (100 ~g/ml) for 30 min at 37°C and then washed twice. Ten assayswere set up on 
each portion and read after varying periods of incubation at 37°C, each point graphed repre- 
senting the mean of two assays. JOHN  W.  SCHRADER  AND  G.  J.  V.  NOSSAL  1587 
TABLE III 
The Effect on the Degree of Inhibition of PFC Numbers of Suboptimal Assay Conditions 
Conditions  of Assay  Controls*  Experlmental$  % inhibition§ 
Standard  100  82  18 
Read at 20 min  H  65  16  75 
66% C'¶  90  68  24 
33% C ~  45  9  80 
16% C'  0  0  -- 
1.8% DNP-SRC  86  45  48 
Spleen cells containing anti-DNP-AFC were incubated with either 100 gg/ml of a prepara- 
tion of DNP-POL~, or HEM alone*, for 30 rain at 37°C and washed twice. Duplicate assays 
were made of the control and experimental aliquots under various assay conditions. Thus the 
standard 60-rain incubation  time was reduced to 20 min,[I, the complement  (C ~) concentra- 
tion was reduced to the indicated  percentage of the standard amount,¶, and the concentra- 
tion of DNP-SRC was increased from the standard 1.25% up to 1.8%. Figures in ~,* represent 
mean PFC/chamber. The calculated percentage inhibition  § is shown for each set of assay 
conditions. The batch of DNP-POL differed from that used in earlier experiments where the 
inhibition  under standard conditions was greater but is used to show more clearly the effect 
of varying assay conditions. 
The Effect  of Assaying Together Pretreated and Control Suspensions.--It  was 
conceivable  that  the  inhibitory  effect  seen  in  these  experiments  was  due  to 
antigen that had been carried over from the preincubation stage into the assay 
and which diffused out into the assay mixture,  thus inhibiting plaque forma- 
tion by competing for secreted antibody with the DNP-SRC  (17).  Therefore, 
aliquots  pretreated  with  DNP-POL  were  mixed  with  aliquots  preincubated 
with  medium  alone,  and  the  mixture  assayed  for  anti-DNP-AFC.  Table  IV 
demonstrates  that  the  presence of cells  from  the "inhibited"  cell suspension 
had no effect on the  emergence of plaques  due  to the AFC from the  control 
suspension.  It was also  noted  that plaque morphology was as expected from 
this; in assays on  the  mixture,  two  populations  of plaques  could  be  distin- 
guished, one of large clear plaques, similar to those in assays of control aliquots, 
the other of small indistinct plaques, similar to those seen in assays of the pre- 
treated aliquot. This indicated that if antigen-carry over is involved, then this 
antigen must be bound to the individual PFC that are inhibited. 
The Effect  of Binding DNP-POL onto Cell Suspensions at 0°C.--Spleen  cell 
suspensions were exposed to DNP-POL at 0°C for 30 rain,  were washed,  and 
then held at 37°C for varying periods before being assayed. Table V shows that 
exposure to DNP-POL at 0°C followed by washing resulted in inhibition of anti- 
DNP-PFC,  provided  that  the  cells  had  been  incubated  at  37°C  for 30 min 
before  entering  the  assay.  This  experiment  suggested  that  DNP-POL  was 
binding to the cell suspension since it is difficult to envisage how contact with 
AFC  at  0°C  could  otherwise  affect  the  subsequent  ability  to form plaques. 
Taken together with the previous mixing experiment which showed that only 1588  EFFECTOR  CELL  BLOCKADE 
TABLE IV 
The Effect of Mixing  Pretreated with Control Cells on  Expected PFC Number 
Pretreatment* 
PFC/chamber 
30m  60 m 
DNP-POL:~  44  4-  7  58  .4-  ll 
Control§  10l  4-  6  102  4.  17 
(73)  (80) 
(DNP-POL-t-control)ll  77  4-  1  (62)  92  -4-  14  (80) 
(DNP-POL)¶  22  4.  2  32  -4-  6 
~j (Control)  40  4.  3  48  -4-  3 
* Portions (0.5 ml) of a pooled spleen suspension from DNP-POL immunized mice, were 
incubated for 30 rain at 37°C with DNP-POL,  (100/zg/ml):~, or medium alone.§  Portions 
were washed twice and resuspended in 4 ml of HEM. Anti-DNP-PFC assays were made of 
these suspensions,  and also of a mixture[[  containing 1 ml of each of:~ and§. Twofold dilutions 
of the experimental$ and control§ suspensions were also assayed.¶  Figures shown in paren- 
theses represent expected results of the  assay  of the mixture,  the upper  figures represent- 
ing the mean ors and§ values, the lower figure the sum of the results of assays on the diluted 
suspensions.¶ 
TABLE V 
The Binding of DNP-POL to Spleen Cell Suspensions at O°C 
PFC/chamber 
Exposure to DNP-POL*  Incubation after washing 
Experimental  Control 
370C  --  126  4-  3  (53)§  237  -4-  10 
0°C  --  258  -4-  22  (118)  218  -4-  22 
0°C  30 min  106  -4-  6  (46)  232  4-  20 
0°C  10 rain  219  4-  24  (98)  224  4-  11 
* Portions  of  spleen  cells containing anfi-DNP-AFC  were  exposed  to  DNP-POL,  100 
#g/ml for 30 rain at either 37°C or 0°C. After washing the spleen cells were assayed imme- 
diately or were incubated at37°C for30 or 10 min before assay. Control portions$ were treated 
in parallel except that DNP-POL was not present. The figures in parentheses,§ represent ex- 
perimental values expressed as a percentage of the respective control. 
those AFC in the pretreated population were affected, the inference is that the 
relevant binding must  be to the AFC  themselves.  These results show that  the 
binding  of antigen  to  the  AFC  could  occur  at  0°C,  while  the  AFC  were  not 
actively secreting  antibody.  Finally  this  experiment  suggests  that  for  the  in- 
hibitory  effect  to  become manifest,  the  cell had  to  be  at  37°C  for a  certain 
period. 
The  Effect  on  IgG-Producing  AFC.--An  additional  finding  was  that  IgG- 
secreting  AFC  could  be inhibited  by a  similar preincubation  with  DNP-POL 
(Table VI).  There  was  no  detectable  change  in  the  susceptibility  to  interfer- JOHN  W.  SCHRADER AND  G.  J.  V.  NOSSAL  1589 
ence with plaque formation of AFC  tested on various days up to the 12th day 
of secondary response. 
The  Importance  of  the  Multivalent  Nature  of  the  Antigen  in  Effector  Cell 
Blockade.--We next studied the capacity of a  variety of DNP  conjugates to act 
as specific inhibitors of AFC  (Table VII).  Highly multivalent  molecules  such 
TABLE  VI 
The Effect on lgG-A FC of Preinvubation witk DNP-POL 
Day after boosting  Prelncubation  with  DNP-POL 
Indirect anti-DNP-PFC/chsmber 
Number  %* 
~g/mt 
3  100  46  -4-  10  52 
--  90  ±  1  I00 
ll  100  58  4-  3  66 
10  103  4-  4  96 
--  107  --I-  6  100 
Spleen cell  suspensions were  prepared  from mice injected  1 mo previously with alum- 
precipitated DNP-FGG plus 2 X  10 ¢ pertussis organisms and boosted 3 days previously with 
100/~g DNP-FGG.  Portions were incubated at 37°C for 30 min with DNP-POL as indicated 
and washed  twice.  In the second experiment mice were killed and spleen cell suspensions 
prepared 11 days after boosting with DNP-FGG. Column* represents PFC numbers expressed 
as a percentage of values in assays of portions incubated with medium alone. 
TABLE  VII 
The Effwacy of Various Multivalent DNP-Conjugates in Effector Call Blockade 
DNP-coniugate  Molarity of DNP 
PFC/chamber 
Anti-DNP  Anti-FGG 
~g/mZ 
DNP-CAP  10  -4  94  ND 
10  -3  100  ND 
DNP4.sHGG  100  3  X  10-  ~  98  105 
"  1,000  3  X  10  -5  80  90 
DNP~o-HGG  10  1.3  X  10- 6  77  102 
"  25  3  X  10  -e  44  99 
"  100  1.3  X  10- 5  40  108 
DNP-D-GL  0.1  7.4  X  10- s  105  100 
"  1  7.4  X  10  -~  57  109 
"  10  7.4  X  10  -6  38  105 
DNP-LPS  25  --*  45  ND 
Spleen cell suspensions containing approximately 1,000  anti-DNP-AFC per ml were in- 
cubated with the indicated amounts of various DNP-conjugates for 30 min at 37°C and washed 
as in previous experiments. Assays were set up in duplicate or quadruplicate and read after 
60 min. In some cases FGG-specific AFC were included in the test suspensions and were as- 
sayed for in parallel. Results are expressed as a  percentage of the mean number of  PFC in 
control portions incubated in medium alone.  * Not measured. ND, not done. 1590  EFFECTOR  CELL  BLOCKADE 
as DNP-LPS  and DNP37-DGL, a  random copolymer of D-glutamic acid and 
I)-lysine with a mean mol wt of 50,000  (18,  19)  were efficient inhibitors. DNP 
lysine (data not shown) or DNP-e-amino-caproic acid were not inhibitors, while 
lightly substituted DNP4.~HGG was only minimally inhibitory in contrast to 
DNP20-HGG. It was clear that valency was a  more important variable than 
hapten molarity. 
Specific  Inhibition  of AFC of  other  Specificities  by  Multivalent  Antigen.- 
Similar effects could be demonstrated with AFC of different specificities. Thus 
anti-FGG  AFC  could  be  inhibited  by prior  incubation  with  a  multivalent 
antigen-antibody  complex formed by the  interaction  of fowl  anti-POL  anti- 
bodies with  POL  (FGG-POL), but not by soluble FGG (Table VIII). Like- 
TABLE  VIII 
Blockade of PFC of Differing Specificities 
Preincubation with: 
PFC/chsmber 
Anti-POL  Anti-FGG 
t~g/r,g 
OXMON  100 
POL  100 
"  10 
FGG  300 
¢c  50 
FGG-POL  100 
"  10 
104 
42 
98 
101 
106 
53 
102 
Spleen cell suspensions containing AFC of appropriate specificities, were incubated with 
the corresponding  antigen as indicated for 30 min at 37°C and washed as before. Assays  were 
set up in duplicate or quadruplicate and read at 60 min. Results represent mean PFC/cham- 
ber expressed as a percentage of values in assays on control portions incubated with me- 
dium alone. 
wise, AFC directed against flagellar antigens were inhibited by POL but not 
by the monomeric form of flagellin, here oxidized to a  form in which repolym- 
erization does not occur (OXMON) (20)  (Table VIII). 
The Importance  of the Substitution  Ratio of the DNP-POL.--Previous  work 
using DNP-POL as a  tolerogen in vitro has stressed the importance of a high 
substitution  rate of DNP  groups in  the induction  of DNP-specific tolerance 
(9). Therefore it was of interest to examine this variable in the present system. 
Table IX shows  that DNP~.9-POL  was more effective than  DNPI.x-POL in 
inhibiting  formation of plaques by anti DNP-AFC. With  DNPI.I-POL some 
inhibition was detectable with preincubation of AFC at 100 pg/ml. Using this 
preparation of DNP~.9-POL, inhibition was marked at  100 #g/ml and detect- 
able at 10 #g/ml, especially in assays read at 30 min (Table IX). 
In Vivo Inhibition of the Expression of PFC Capacity.--Mice which had been 
injected with DNP-POL, 5 pg i.p., 4 days previously were injected with various JOHN  W.  SCHRADER  AND  G.  J.  V.  NOSSAL  1591 
DNP  conjugates intravenously. 4  h  later the mice were killed and the spleens 
assayed for PFC. Table X  shows that PFC numbers were decreased in animals 
injected with suitable doses of DNP  conjugates. It was striking that, as in the 
in vitro experiments, the plaques formed by those AFC escaping total inhibi- 
tion were faint and small. 
TABLE IX 
The Effect  of Incubation  of PFC with DNP-POL of Different  Substitution  Ratios* 
Concentration  Molarity DNP  DNP per MON  DNP-POL 
PFC/chamber 
30 min  60 rain 
R 
1.l 
2.9 
ug/mt  %  % 
--  --  50  4-  8§  10011  68  4-  2§  100[I 
100  2.8  x  10  -6  41  -¢- 2  82  51  4- 4  75 
10  2.8  x  10  -~  38  4-  1  76  73  4-  6  107 
100  7.2  x  10- 6  5  4-  2  IO  29  4-  9  43 
10  7.2  X  10-  ~  27  4-  3  54  52  -4-  1  77 
* Portions of anti-DNP-AFC were incubated for 30 min at 37°C with DNP-POL of two 
substitution ratios;~ at the concentrations indicated. Mter washing  twice, PFC assays were 
set up, one cohort being read at 30 min, the other at 60 min. Results are expressed as mean 
PFC/chamber,§ and also as a percentage of the control value.l[ 
TABLE X 
In Vivo Inhibition  of A nti-DNP-PFC 
Pretreatment of mice  Anti-DNP PFC/Spleen  Plaque morphology 
--  6,050  4-  600  Large, clear 
DNP-Gelatine l0 mg  4,350  4-  1,900  Small, turbid 
DNP-DGL 500 #g  2,300  4-  230  Very small, very turbid 
CBA mice which had been injected 3 days previously with DNP-POL were injected intra- 
venously in groups of three with the indicated amounts of two DNP-conjugates. 4 h later 
mice were killed and the spleens assayed individually  for anti-DNP-PFC. Results are expressed 
as the mean AFC/spleen 4- the SE of the mean. 
Antibody  Does  not  Accumulate  on  the  Surface  of Inhibited  AFC.--The  two 
explanations for the interference with plaque formation by AFC seen in this 
study are (a) that antigen is adherent to the AFC where it traps antibody as it 
is secreted, thus preventing diffusion out into the plaque-revealing monolayer 
and  (b)  that  there is an actual diminution of antibody secretion by the cell. 
Therefore a  micromanipulation technique was employed to determine directly 
the amount of immunoglobulin on the surface of individual AFC from inhibited 
and normal populations. Preliminary experiments showed that inhibition could 
be satisfactorily demonstrated by PFC assays in the microdrop system (Fig. 3). 
Thus with appropriate concentrations of DNP-SRC and complement, a definite 
inhibitory effect in terms of rate of plaque appearance and final number could 1592  EFFECTOR CELL BLOCKADE 
be  shown,  but  by  20  rain  some  inhibited  AFC  were revealed  and  could  be 
selected  by micromanipulation.  After 20 rain  AFC  were taken  from definite 
plaques,  irrespective of plaque size, in the order in which they were encoun- 
tered on the slide, one AFC being taken alternately  from the control and ex- 
perimental groups of drops. Individual AFC were held at 0°C or 37°C for 20-30 
rain  in 0.1  #g/ml  of  [mI]RAMG,  were washed twice,  and  then  spread  indi- 
vidually for radioautography.  Table XI shows the resultant  grain counts. As 
expected from previous  work  (14),  there  was a  considerable  scatter  in grain 
20  // 
/  / 
I 
I 
I 
1 
/_  / 
J~,~'  i  i  i  I  I 
5  I0  15  20  25  30 
MINUTES  OF  INCUBATION 
I 
35 
Fro. 3.  Time of appearance of plaques made by control or preinhibited AFC in micro- 
droplets. Anti-DNP-AFC were incubated at 37°C for 30 min with HEM alone or with DNP- 
POL, 100 #g/ml and washed as before. 20 microdroplets assays were then set-up for control 
(O--O)  and  experimental (O---C))  aliquots and  the plaque numbers counted in  each at 
succeeding intervals. 
TABLE  XI 
Radioautographic  Studies on Single  Cells to Detect Surface-Bound  Ig on Normal and Preinhibited 
PFC using [1251]Antiglobulin 
Nature of PFC  Temperature during  No. of PFC  Grain count  P  value 
antiglobulin  binding  studied  Mean -4- SE  Range  (t test) 
°C 
Preinhibited  37  17  28.1  -t-  8.4  0-124  NS 
Control  37  19  23.7  -4-  5.4  0-74  NS 
Preinhibited  0  19  29.0  -4-  6.8  0-105  NS 
Control  0  16  19.5  -t-  4.1  0-61  NS 
Preinhibited or control cells were placed in plaque-revealing microdrops under parat~n oil. 
Control PFC were removed by rnicromanipulation, washed, and placed in 0.1  #g/ml [ls~I]- 
antiglobulin. After binding for 20-30 rain in the 37 ° group, or 30 rain in the 0  ° group, the 
cells were processed for radioautography. JOHN  W. SCHRADER  AND  G. J. V. NOSSAL  1593 
counts in the control population, reflecting variation in accessible surface Ig 
amongst  PFC.  A  similar  variation  was  encountered  amongst  preinhibited 
PFC, and there was no significant difference between the populations in terms 
of labelling with [lsSI]RAMG.  Thus there was no evidence that PFC from the 
inhibited  population  had  on  the  average  accumulated  greater  amounts of 
antibody on their surface. This conclusion is valid only if the attached antigen 
does not sterically hinder access of [t25I]RAMG to cell surface Ig. 
Blockade  Studies  on  Single,  Normal  PFC  Using  Micromanipulation  Tech- 
niques.--We wished to show directly that a  given PFC could be subjected to 
blockade, and could thereby be forced to reduce its antibody secretion rate, 
without having its viability impaired. Micromanipulation offered this oppor- 
tunity. Single, anti-DNP-PFC were taken from the center of normal hemolytic 
plaques within the first 20 rain of incubation of DNP-POL immunized spleen 
cells  in  plaque-revealing  droplets.  Each  single  cell  was  washed  twice,  and 
placed in one of two coded droplets, the one containing HEM-FCS alone, the 
other DNP-POL,  usually at  a  concentration of 100/zg/ml.  After 30 min  at 
37°C, each cell was washed twice and micromanipulated into a plaque-revealing 
drop. With  the aid  of an eye-piece vernier, the area of hemolysis appearing 
over the next 30 rain at 37°C was repeatedly measured, It was noted that, after 
a latent period, the area of hemolysis was directly proportional to incubation 
time. At the conclusion of each experiment, the results were decoded. The re- 
sults of a pool of experiments are given in Table XII. It is shown that plaque 
size was inhibited by an average of 68%  through effector cell blockade, the 
effect being statistically significant. 
In a  separate study, involving 22 PFC,  cells were taken in pairs,  approxi- 
mately matched for plaque diameter at the first selection stage, and consciously 
assigned to blockading or control droplets in such a manner that the PFC form- 
ing the bigger plaque always went into inhibitor, and that forming the smaller 
into medium  alone.  After only 15  rain  at  37°C,  the  cells were  assessed  for 
hemolytic capacity, and,  even with  this intentional  bias  introduced,  a  62 % 
inhibition of plaque size through blockade was noted. 
TABLE XII 
Diminution in Antibody Secretion Rate Resulting from Blockade of Single PFC by DNP-POL 
Nature of inhibitor  No. of PFC  Area of hemolysis  at  studied  20 rain  O~t X  10-4)  P value (t test) 
Me,  an .4- SE 
Medium only  11  13 -4- 3.9  0.02  < P  <  0.05  100/~g/ml DNP-POL  12  4.2  -4- 0.27 
Single PFC were taken from anti-DNP plaques by micromanipulation, blindly assigned 
to control or inhibitor microdrops,  and then assessed for antibody-secreting  rate by measuring 
plaque diameter at successive time intervals. The area of hemolysis  was plotted against time, 
and resulted in a straight line. The mean area of hemolysis  at 20 rain is shown above. 1594  EFFECTOR  CELL  BLOCKADE 
DISCUSSION 
This study shows that the appearance of PFC can be specifically inhibited by 
prior contact of the AFC with a multivalent form of the antigen. The magnitude 
of this inhibition was inversely proportional to the sensitivity of the assay, and 
micromanipulation studies showed that inhibition involved a decreased rate of 
antibody secretion by individual AFC. The mechanism of the blockade effect 
is not clear. The present experiments, especially those where the spleen cells are 
exposed to DNP-POL at 0°C and then washed before warming to 37°C (Table 
V)  imply that the antigen is binding to  the spleen cells.  Since the effect is 
antigen-specific such  binding is likely to  be  to  the  specific  immunoglobulin 
receptors. In this connection the reported increasing sparsity of immunoglobu- 
lin receptors on more mature AFC  (14)  is of interest since the inhibition of 
IgG-AFC 11 days after boosting was still potent (Table VI). It is possible that 
the increased affinity of the few receptors of more differentiated AFC appearing 
later in the response, may account for their suppression. In any case, the effect 
does not depend on the killing of PFC, as the single cell  experiments show 
clearly. 
The present experiments demonstrate that multivalent thymus-independent 
antigens can inhibit the expression of an immune response at the level of the 
final effector cell, a cell usually thought of as autonomous and not subject to 
regulation by antigen. The effect is sufficiently profound in some cases,  par- 
ticularly where  plaque  revelation is  suboptimal,  to  raise  the  issue  whether 
certain  phenomena  regarded  as  tolerance  might  represent  no  more  than  a 
blockade  of  the  AFC  by persisting  antigen.  Baker  et  al.  (21)  investigated 
tolerance to pneumococcal polysaccharide in vivo, and noted an effect which 
we believe to be due to the phenomenon described in this paper. As antigen 
doses were raised from optimally immunogenic to subtolerogenic, they showed 
a decrease in secretion rate by individual AFC. Similarly, Table X  shows that 
our phenomenon can  operate  in vivo,  suggesting a  parallel  to  the  work of 
Mitchell and Humphrey (22),  who blocked anti-DNP responses by injecting, 
early in  the  response,  DNP-pneumococcal  polysaccharide.  Furthermore,  in 
other examples of  ."tolerance" to multivalent, persistent  antigens  (23,  24), 
increased numbers of antigen-binding cells have been noted. These could repre- 
sent blocked AFC. 
In certain models, the tolerant state is rapidly reversed on transfer of cell 
populations to an antigen-free environment such as a lethally X-irradiated host 
(2, 25). This probably reflects the shedding of cell-bound antigen, in some way 
responsible  for holding the cells  "tolerant." Some multivalent antigens like 
levan which do not demonstrate such reversibility (26),  may have a  higher 
avidity for the surface of immunocompetent cells and not be shed, as discussed 
by Kotlarski et al. (27). While this paper has shown that the actual AFC can 
be blocked by multivalent antigen, similar mechanisms could operate at the 
level of the B-cell progenitor of AFC. In that case, B cells with excess attached JOHN  W.  SCHRADER  AND  G.  J.  V.  NOSSAL  1595 
multivalent antigen might be inhibited from division and differentiation.  This 
could be regarded  as a true central tolerance of B cells but differing from that 
caused by oligovalent, T-cell dependent antigens (6). It may be significant that 
only in the case of B-cell tolerance  to thymus-dependent antigens is there an 
actual decrease in numbers of antigen-binding cells (28). 
It is possible that soluble complexes of antigen and antibody formed in slight 
antigen excess may induce effector cell blockade. These complexes are powerful 
suppressors of humoral responses (29, 30), and may be  involved in blocking the 
cytotoxic killing of tumor cells by lymphocytes (31). Blocking effects at the 
T-cell level may represent  a similar phenomenon to that described here at the 
level of the AFC. Finally, if highly multivalent, poorly degradable  antigens 
readily blockade T cells, their inefficiency in producing delayed hypersensitivity 
or IgG antibody  production, that requires T-cell help (32) is explained. 
The possibility of a  regulatory role for multivalent antigens and immune 
complexes at the level of the actual effector cells has many implications for the 
study of immune regulation.  The mechanism of the phenomenon  at cell bio- 
logic and molecular levels presents a challenge for the immediate future. 
SUMMARY 
This study describes the effects of incubating antibody-forming cells (AFC), 
either as mass cell suspensions, or as single AFC in microdroplets, with antigens 
against which  the cells display specificity. Most of the work was done with 
hapten-specific  anti-DNP-AFC,  but  AFC  with  specificity  against  flagellar 
antigens or fowl gamma globulin (FGG) were also included. It was noted that 
30-rain incubation of AFC with highly multivalent forms of antigen caused a 
substantial partial  suppression  of the  antibody-forming performance  of the 
AFC as measured by a hemolytic plaque test. Thus, when cell suspensions con- 
taining anti-DNP plaque-forming  cells (PFC), were incubated for 30 min at 
37°C with 100 #g of DNP-polymerized flagellin (DNP-POL),  the number of 
plaques  appearing  after washing  of  the  cells and  placing  them in  plaque- 
revealing erythrocyte monolayers  was reduced to 50 % or less compared  with 
the  number  of  plaques  observed  with  control  portions  preincubated  with 
medium alone. Preincubation with DNP-lysine, with oligovalent DNP-protein 
conjugates,  or with irrelevant antigens produced no such  inhibition.  Studies 
where preinhibited PFC suspensions were mixed with control suspensions before 
assay showed  that a  nonspecific carryover of antigen into the assay system 
was not involved. The inhibitory effect could also be initiated by holding cells 
at 0°C with DNP-POL, but in that case, inhibition only became manifest after 
cells were incubated for 30 min at 37°C before being placed in plaque-revealing 
monolayers.  This  suggested  that  inhibition  was  initiated by adsorption  of 
multivalent antigen onto PFC-surface Ig,  but  required  some active process 
before  secretion  actually slowed  down.  The  effect  was  dose-  and  time-de- 
pendent, antigen-specific, and generalized for all antigens studied. 1596  EFFECTOR  CELL BLOCKADE 
As well as yielding reduced plaque numbers, the preinhibited cells also gave 
smaller, more turbid plaques, suggesting a reduction in antibody-forming rate 
by each PFC rather than the elimination of PFC. Consistent with this sugges- 
tion was the observation that the degree of inhibition of plaque formation could 
be increased by decreasing the sensitivity of the assay so that only AFC secret- 
ing at high rates were detected. A micromanipulation study, where single PFC 
were subjected to inhibition, and were then tested for the rate at which they 
could cause hemolysis, showed a 68 % inhibition of mean secretory rate. 
Micromanipulation studies were performed to test the amount of cell surface- 
associated Ig on control and preinhibited PFC. For this, single PFC were held 
with  [~SI]antiglobulin and  quantitative  radioautography  was  performed. No 
significant difference emerged, suggesting that retention of secreted Ig on cell- 
attached antigen was not the cause of inhibition. 
The results are discussed in the framework of tolerance models and blocking 
effects at the T-cell level by antigen-antibody complexes. The name effector 
cell blockade is suggested in the belief that the phenomenon may be a general 
one applying to both T  and B cells. 
Mr. John Pye performed the radioiodinations. The technical assistance of Ms. H. King, 
J. Jackson, and K. Davern is gratefully appreciated. 
REFERENCES 
1.  Weigle, W. O. 1973. Immunological unresponsiveness. Adv. Immunol.  16:61. 
2.  Howard, J.  G.  1972. Cellular  events in  the induction  and loss of tolerance  to 
pneumococcal polysaccharides.  Transplant. Rev. 8:50. 
3.  Feldmann, M., and G. J. V. Nossal. 1972. Tolerance, enhancement and the regu- 
lation of interactions between  T  cells, B  cells and macrophages.  Transplant. 
Rev. 13:3. 
4.  Britton, S. 1969. Regulation  of antibody synthesis against Escherichia coli endo- 
toxin. IV. Induction of paralysis in vitro by treating normal lymphoid cells with 
antigen. J. Exp. Med. 19.9:469. 
5.  Claman,  H. N. 1963. Tolerance to a protein antigen in adult mice and the effect 
of nonspecific factors. J. Immunol. 91:833. 
6.  Schrader,  J. W.  1974. The induction  of immunological  tolerance to a  thymus- 
dependent antigen in the absence of thymus-derived cells. J. Exp. Med.  139: 
1303. 
7.  Ada, G. L., G. J. V. Nossal, J. Pye, and A. Abbott. 1964. Antigens in immunity. 
I.  Preparation  and  properties of flagellar  antigen  from Salmonella adelaide. 
Aust. J. Exp. Biol. Med. Sci. 42,:267. 
8.  Williams,  C.  A.,  and  M.  W.  Chase,  Editors.  1967. Methods  in  Immunology. 
Academic Press, New York. 1:236. 
9.  Feldmann, M.  1972. Induction of immunity and  tolerance in vitro by hapten 
protein conjugates.  I. The relationship between  the degree of hapten conjuga- 
tion  and  the  immunogenicity  of dinitrophenylated polymerized  flagellin. J. 
Exp. Meal. 135:735. 
10.  Cunningham,  A., and A. Szenberg.  1968. Further improvements on the plaque 
technique for detecting single antibody-forming cells. Immunology.  14:599. JOHN W.  SCHRADER AND G.  J.  V.  NOSSAL  1597 
11.  Miller, J. F. A. P., and N. L. Warner.  1971. The immune responses of normal ir- 
radiated and thymectomized mice to fowl immunoglobulin G as detected by a 
hemolytic plaque technique. Int. Arch. Allergy A ppl. Immunol.  40:59. 
12.  Langman, R. E.  1972. The use of erythrocytes sensitized with flagellar antigens 
from  Salmonella  for  the  assay  of  antibody  and  antibody-forming  cells.  J. 
Immunol.  Methods. 2:59. 
13.  Nossal, G. J. V., A. J. Cunningham, G. F. Mitchell, and J. F. A. P. Miller.  1968. 
Cell  to  cell  interaction  in  the  immune  response.  III.  Chromosomal marker 
analysis  of single  antibody-forming cells  in reconstituted,  irradiated,  or thy- 
mectomized mice. J. Exp. Med. 128:839. 
14.  Nossal, G. J. V., and H. Lewis. 1972. Variations in accessible  cell surface immuno- 
globulin among antibody-forming cells. J. Exp. Med. 185:1416. 
15.  Nossal,  G.  J.  V.,  N.  L.  Warner,  II. Lewis,  and  J.  Sprent.  1972. Quantitative 
features of a  sandwich radioimmuno labeling technique for lymphocyte surface 
receptors. J. Exp. Med. 135:405. 
16.  Hiromoto, R. N., J. R. McGhee, and N. M. Hamlin. 1972.  Measurement of anti- 
body release from single cells. J. Immunol.  109:961. 
17.  Andersson, B. 1970. Studies on the regulation of avidity at the level of the single 
antibody-forming cell. The effect of antigen dose and time after immunization. 
J. Exp. Med. 182:77. 
18.  Katz, D. H., J. M. Davie, W. E. Paul, and B. Benaceraff, 1971. Carrier function 
in antihapten antibody responses.  IV. Experimental conditions for the induction 
of hapten-specific  tolerance  or for the stimulation  of antihapten  anamnestic 
responses  of  nonimmunogenic hapten-polypeptide  conjugates.  J.  Exp.  Med. 
134:201. 
19.  Nossal, G. J. V., B. Pike and D. H. Katz. 1973. Induction of B-cell tolerance in 
vitro  to  2,4-dinitrophenyl  coupled  to  a  copolymer of  D-glutamic  acid  and 
D-lysine  (DNP-D-GL). J. Exp. Med. 138:312. 
20.  Parish,  C. R.  1971. Immunochemical studies of bacterial flagellin.  Ph.D. Thesis. 
University of Melbourne, Melbourne, Australia. 
21.  Baker,  P. J.,  P. W. Stashak,  D.  F. Amsbaugh, and B. Prescott,  1971.  Charac- 
terization of the antibody response to Type III pneumococcal polysaccharide 
at the cellular level.  II. Studies on the relative rate of antibody synthesis and 
release by antibody producing cells. Immunology. 9.0:481. 
22.  Mitchell,  G.  F.,  J.  H.  Humphrey,  and  A.  R.  Williamson.  1972.  Inhibition  of 
secondary anti-hapten responses with the hapten conjugated to type III pneu- 
mococcal polysaccharide. Eur. J. Immunol.  9.:460. 
23.  Sj6berg,  O.,  and  E.  Moiler.  1970.  Antigen-binding  cells  in  tolerant  animals. 
Nature  (Lond.). 29.8:78. 
24.  Howard, J. G., J. Elson, G. H. Christie, and R. G. Kinsky. 1969. Studies on im- 
munological paralysis. II. The detection and significance  of antibody forming 
cells in the spleen during immunological paralysis with Type III pneumococcal 
polysaccharide. Clin. Exp. lmmunol.  4:41. 
25.  Sjtiberg,  O.  1972. Rapid breaking of tolerance against Escherichia Coli lipopoly- 
saccharide in vivo and in vitro. J. Exp. Med. 135:850. 
26.  Miranda,  J.  J.,  Zola,  H.,  and  Howard, J.  G.  1972.  Studies  on Immunological 
paralysis X.  Cellular  characteristics  of the induction and  loss  of tolerance  to 
levan (polyfructose). Immunology. 23:843. 1598  EFFECTOR CELL BLOCKADE 
27.  Kotlarski, I., Courtenay, B. M., and Howard, J. A.  1973. Tolerogenicity in vitro 
of levan and type B pneumococcal polysaccharide. Eur. J. Immunol. 8:496. 
28.  Louis, J., J. M. Chiller,  and W. O. Weigle. 1972. Quantitation of antigen-binding 
cells to HGG in normal, immune and unresponsive mice. Fed. Proc. Amer. Soc. 
Exp. Biol. 31:655. 
29.  Diener, E., and M. Feldmann.  1971. Relationship between antigen and antibody 
induced suppression  of immunity. Transplant. Rer. 8:76. 
30.  Feldmann,  M.  1973. Induction  of  B-cell  tolerance  by antigen  specific  T  cell 
factor. Nat. New Biol. 242:82. 
31.  SjSgren, H. O., I. Hellstrom, S. C. Bansal, and K. E. Hellstrom. 1971. Suggestive 
evidence that the "blocking antibodies" of tumour-bearing individuals may be 
antigen-antibody complexes. Proc. Natl. Acad. Sci. U. S. A. 68:1372. 
32.  Taylor, R. B., and H. N. Wortis. 1968. Thymus dependence of antibody response: 
variation with dose of antigen and class of antibody. Nature (Lond.). 9.20:927. 